Active	Status	Sponsor type	Region	Phase	Filter
7 Active 0 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Black, Jennifer
ACT in TSC, NCT05867576: Acceptance and Commitment Therapy in Tuberous Sclerosis Complex	Active, not recruiting	N/A	15	Europe	Acceptance and Commitment Therapy (ACT)	University Hospitals Bristol and Weston NHS Foundation Trust, The Tuberous Sclerosis Association, University College, London	Tuberous Sclerosis Complex	03/24	03/24
Investigator, Chief
TRIFOUR, NCT05181462 / 2021-003402-46: Nadunolimab in Combination with Gemcitabine Plus Carboplatin in Patients with Advanced Triple Negative Breast Cancer.	Recruiting	1/2	116	Europe	Carboplatin, Gemcitabine, Nadunolimab, CAN04	Cantargia AB, Spanish Breast Cancer Research Group	Triple Negative Breast Cancer	06/25	08/26
NCT04817449: Spectroscopy in Ovarian Cancer	Active, not recruiting	N/A	160	Europe		University of Exeter, University Hospitals Bristol and Weston NHS Foundation Trust	Ovarian Cancer, Ovarian Neoplasms, Ovary Cyst, Ovary Disease	10/23	10/25
Amin, Sam
TrustTSC, NCT05323734 / 2021-003441-38: Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy	Completed	3	128	Europe, Canada, US, RoW	Ganaxalone, Placebo	Marinus Pharmaceuticals, Marinus Pharmaceuticals Inc., Marinus Pharmaceuticals, Inc.	Tuberous Sclerosis Complex	09/24	10/24
RAD-GRIN-201, NCT06392009: Astroscape: a Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients with TSC or FCD Type II	Recruiting	1/2	30	Europe, Canada, RoW	Radiprodil	GRIN Therapeutics, Inc.	Tuberous Sclerosis Complex, Focal Cortical Dysplasia	07/25	07/26
ACT in TSC, NCT05867576: Acceptance and Commitment Therapy in Tuberous Sclerosis Complex	Active, not recruiting	N/A	15	Europe	Acceptance and Commitment Therapy (ACT)	University Hospitals Bristol and Weston NHS Foundation Trust, The Tuberous Sclerosis Association, University College, London	Tuberous Sclerosis Complex	03/24	03/24
Mulligan, Sandra
ACT in TSC, NCT05867576: Acceptance and Commitment Therapy in Tuberous Sclerosis Complex	Active, not recruiting	N/A	15	Europe	Acceptance and Commitment Therapy (ACT)	University Hospitals Bristol and Weston NHS Foundation Trust, The Tuberous Sclerosis Association, University College, London	Tuberous Sclerosis Complex	03/24	03/24